Versor Investments LP Sells 17,798 Shares of CVS Health Corporation $CVS

Versor Investments LP lessened its stake in CVS Health Corporation (NYSE:CVS) by 32.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,695 shares of the pharmacy operator’s stock after selling 17,798 shares during the period. CVS Health accounts for 0.5% of Versor Investments LP’s portfolio, making the stock its 20th largest holding. Versor Investments LP’s holdings in CVS Health were worth $2,766,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of the company. Avion Wealth boosted its holdings in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. lifted its position in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC bought a new position in shares of CVS Health in the 3rd quarter valued at about $29,000. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the 2nd quarter worth approximately $30,000. Finally, Front Row Advisors LLC raised its stake in shares of CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CVS. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. TD Cowen increased their target price on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Finally, Wells Fargo & Company cut their price target on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $94.82.

CVS Health Trading Down 2.9%

NYSE CVS opened at $76.06 on Tuesday. CVS Health Corporation has a one year low of $53.36 and a one year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm has a market cap of $96.55 billion, a P/E ratio of 200.16, a P/E/G ratio of 0.72 and a beta of 0.50. The stock’s 50-day moving average is $78.56 and its 200-day moving average is $75.87.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.